Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Huangbao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1537-6951; OpenAlex author ID A5041294394. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 6

  1. Impact of microvasculature invasion subtype (MVI vs. LVI) and associated risk factors on survival outcomes in pancreatic cancer after curative surgery. Co-author DOI 10.1186/s12957-025-04131-3↗
  2. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images. Last author DOI 10.1186/s12876-024-03469-4↗
  3. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study. Co-author DOI 10.1186/s12885-024-11948-w↗
  4. Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Co-author DOI 10.12659/msm.930545↗
  5. Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer. Co-author DOI 10.2147/cmar.s251897↗
  6. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenec… Co-author DOI 10.12659/msm.909649↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fengqing Zhao · 6 shared papers, 2018–2025 · strength 1.26
  2. Hongkun Zhou · 1 shared paper, 2024 · strength 0.28
  3. Kun Tong · 1 shared paper, 2024 · strength 0.28
  4. Jie Yang · 1 shared paper, 2024 · strength 0.28
  5. Kaixin Hu · 1 shared paper, 2024 · strength 0.24
  6. Dawei Jiang · 1 shared paper, 2024 · strength 0.24
  7. Liu Xu · 1 shared paper, 2021 · strength 0.16
  8. Longsheng Xu · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.